sulotroban has been researched along with Muscle Contraction in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dack, KN; Dickinson, RP; Long, CJ; Steele, J | 1 |
| Müller-Beckmann, B; Patscheke, H; Pill, J; Schmidt, FH; Stegmeier, K; Witte, EC; Wolff, HP | 1 |
| Andersson, KE; Forman, A; Skajaa, K; Svane, D | 1 |
| Shikada, K; Tanaka, S; Yamamoto, A | 1 |
| Higo, K; Karasawa, A; Kubo, K; Shirakura, S | 1 |
| Aksoy, MO; Harakal, C; Smith, JB; Stewart, GJ; Zerweck, CR | 1 |
| Battistini, B; Filep, JG; Sirois, P | 1 |
| Battistini, B; Filep, J; Sirois, P | 1 |
| Bolofo, ML; Giles, H; Kelly, MG; Leff, P; Robertson, AD | 1 |
| Deckmyn, H; Gresele, P; Janssens, WJ; Vermylen, J | 1 |
10 other study(ies) available for sulotroban and Muscle Contraction
| Article | Year |
|---|---|
Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Oral; Animals; Dogs; Drug Design; Enzyme Inhibitors; Imidazoles; Microsomes; Molecular Structure; Muscle Contraction; Phenylpropionates; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Rats; Receptors, Thromboxane; Structure-Activity Relationship; Thromboxane-A Synthase; Thromboxanes | 1997 |
The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Epoprostenol; Female; Fibrinolytic Agents; Guinea Pigs; Male; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Rabbits; Sulfonamides; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxanes | 1984 |
Effects of the thromboxane-receptor antagonists AH 23848 and BM 13.177 on human uteroplacental arteries.
Topics: Adult; Arteries; Biphenyl Compounds; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Muscle Contraction; Placenta; Pregnancy; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxanes; Uterus; Vasoconstriction; Vasopressins | 1992 |
NIP-121 and cromakalim, potassium channel openers, preferentially suppress prostanoid-induced contraction of the guinea-pig isolated trachea.
Topics: Animals; Arachidonic Acid; Benzopyrans; Cromakalim; Dinoprost; Glyburide; Guinea Pigs; Indomethacin; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Oxadiazoles; Piperidines; Potassium Channels; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Pyrroles; Sulfonamides; Trachea | 1991 |
Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Benzimidazoles; Benzoxepins; Blood Pressure; Cats; Dogs; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Phenylacetates; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Rabbits; Rats; Rats, Inbred Strains; Species Specificity; Sulfonamides; Thromboxane A2 | 1991 |
Mediation of bradykinin-induced contraction in canine veins via thromboxane/prostaglandin endoperoxide receptor activation.
Topics: Animals; Bradykinin; Bridged Bicyclo Compounds, Heterocyclic; Dogs; Endothelium, Vascular; Fatty Acids, Unsaturated; Female; Hydrazines; Imidazoles; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandin-Endoperoxide Synthases; Prostaglandins H; Pyridines; Receptors, Prostaglandin; Sulfonamides; Thromboxane-A Synthase; Thromboxanes; Veins | 1990 |
Endothelin induces thromboxane release and contraction of isolated guinea-pig airways.
Topics: Animals; Anti-Arrhythmia Agents; Bronchi; Dose-Response Relationship, Drug; Endothelins; Epoprostenol; Guinea Pigs; Lung; Male; Muscle Contraction; Muscle, Smooth; Phenylacetates; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes; Trachea | 1990 |
Potent thromboxane-mediated in vitro bronchoconstrictor effect of endothelin in the guinea-pig.
Topics: Animals; Bronchi; Endothelins; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Peptides; Sulfonamides; Thromboxane A2; Thromboxanes; Trachea | 1990 |
The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Platelets; Blood Vessels; Guinea Pigs; Humans; Hydantoins; In Vitro Techniques; Jugular Veins; Male; Muscle Contraction; Platelet Aggregation; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Rabbits; Receptors, Prostaglandin; Sulfonamides; Trachea | 1989 |
BM 13.177 selectively inhibits endoperoxide analogue induced vascular contractions.
Topics: Animals; Fibrinolytic Agents; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides, Synthetic; Rabbits; Sulfonamides | 1985 |